MetaADEDB 2.0 @ LMMD
Hydrocodone
(OJHZNMVJJKMFGX-BWCYBWMMSA-N)
Structure
SMILES
O[C@H]([C@H](C(=O)O)O)C(=O)O.COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4CCC1=O)C
Molecular Formula:
C22H27NO9
Molecular Weight:
449.451
Log P:
-0.2514
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
153.83
CAS Number(s):
143-71-5
Synonym(s)
1.
Hydrocodone
2.
Dihydrocodeinone
3.
Hydrocodeinonebitartrate
4.
Hydrocon
5.
Codinovo
6.
Dicodid
7.
Hycodan
8.
Hycon
9.
Hydrocodon
10.
Hydrocodone Bitartrate
11.
Hydrocodone Tartrate (1:1), Hydrate (2:5)
12.
Robidone
External Link(s)
MeSHD006853
PubChem Compound5463977
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 373US FAERS
2NauseaFAERS: 347US FAERS
3Inadequate analgesiaFAERS: 181US FAERS
4HeadacheFAERS: 157US FAERS
5SomnolenceFAERS: 123US FAERS
6DizzinessFAERS: 109
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Feeling abnormalFAERS: 101US FAERS
8VomitingFAERS: 96US FAERS
9PainFAERS: 64US FAERS
10PruritusFAERS: 61US FAERS
11FatigueFAERS: 50US FAERS
12Abdominal discomfortFAERS: 49US FAERS
13ConstipationFAERS: 44US FAERS
14MalaiseFAERS: 38US FAERS
15Drug withdrawal syndromeFAERS: 27US FAERS
16AnxietyFAERS: 17US FAERS
17HypersensitivityFAERS: 16US FAERS
18Unevaluable eventFAERS: 16US FAERS
19UrticariaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Medication residue presentFAERS: 15US FAERS
21OverdoseFAERS: 15US FAERS
22PalpitationsFAERS: 15US FAERS
23Wrong technique in product usage processFAERS: 13US FAERS
24Breakthrough PainFAERS: 12US FAERS
25Euphoric moodFAERS: 12US FAERS
26Inappropriate schedule of drug administrationFAERS: 12US FAERS
27Peripheral swellingFAERS: 12US FAERS
28TremorFAERS: 12US FAERS
29Abdominal PainFAERS: 11US FAERS
30Intentional product use issueFAERS: 11US FAERS
31Chest PainFAERS: 10US FAERS
32Drug abuseFAERS: 10US FAERS
33Feeling jitteryFAERS: 10US FAERS
34LethargyFAERS: 10US FAERS
35AgitationFAERS: 9US FAERS
36Chest discomfortFAERS: 9US FAERS
37AstheniaFAERS: 8US FAERS
38Extra dose administeredFAERS: 8US FAERS
39RestlessnessFAERS: 7US FAERS
40TinnitusFAERS: 7US FAERS
41Weight decreasedFAERS: 7US FAERS
42Drug effect incompleteFAERS: 6US FAERS
43Drug level increasedFAERS: 6US FAERS
44NervousnessFAERS: 6US FAERS
45Respiratory DepressionFAERS: 6US FAERS
46ChokingFAERS: 5US FAERS
47Depressed moodFAERS: 5US FAERS
48DisorientationFAERS: 5US FAERS
49DysarthriaFAERS: 5US FAERS
50Memory impairmentFAERS: 5US FAERS
51Oropharyngeal painFAERS: 5US FAERS
52Pharmaceutical product complaintFAERS: 5US FAERS
53Restless Legs SyndromeFAERS: 5US FAERS
54SwellingFAERS: 5US FAERS
55Urinary RetentionFAERS: 5US FAERS
56Urinary tract infectionFAERS: 5US FAERS
57Activities of daily living impairedFAERS: 4US FAERS
58Back PainFAERS: 4US FAERS
59Burning sensationFAERS: 4US FAERS
60Cardiac ArrestFAERS: 4US FAERS
61Drug DependenceFAERS: 4US FAERS
62Drug prescribing errorFAERS: 4US FAERS
63Drug toxicityFAERS: 4US FAERS
64DyspepsiaFAERS: 4US FAERS
65Erectile dysfunctionFAERS: 4US FAERS
66FlatulenceFAERS: 4US FAERS
67FlushingFAERS: 4US FAERS
68Incorrect dose administeredFAERS: 4US FAERS
69InfluenzaFAERS: 4US FAERS
70MalabsorptionFAERS: 4US FAERS
71Urinary hesitationFAERS: 4US FAERS
72AngerFAERS: 3US FAERS
73ArthralgiaFAERS: 3US FAERS
74BedriddenFAERS: 3US FAERS
75DysgeusiaFAERS: 3US FAERS
76Feeling ColdFAERS: 3US FAERS
77Foreign body in respiratory tractFAERS: 3US FAERS
78HypotensionFAERS: 3US FAERS
79NasopharyngitisFAERS: 3US FAERS
80Night sweatsFAERS: 3US FAERS
81PneumoniaFAERS: 3US FAERS
82Product physical issueFAERS: 3US FAERS
83Product size issueFAERS: 3US FAERS
84Skin reactionFAERS: 3US FAERS
85Toxicity to various agentsFAERS: 3US FAERS
86Visual ImpairmentFAERS: 3US FAERS
87Accidental overdoseFAERS: 2US FAERS
88AlopeciaFAERS: 2US FAERS
89AmnesiaFAERS: 2US FAERS
90AsthmaFAERS: 2US FAERS
91Cartilage injuryFAERS: 2US FAERS
92Cerebrovascular accidentFAERS: 2US FAERS
93Completed SuicideFAERS: 2US FAERS
94DehydrationFAERS: 2US FAERS
95DiscomfortFAERS: 2US FAERS
96Documented hypersensitivity to administered drugFAERS: 2US FAERS
97Drug effect delayedFAERS: 2US FAERS
98Drug effect variableFAERS: 2US FAERS
99DysuriaFAERS: 2US FAERS
100EructationFAERS: 2US FAERS
101ErythemaFAERS: 2US FAERS
102Head discomfortFAERS: 2US FAERS
103HypersomniaFAERS: 2US FAERS
104Impaired driving abilityFAERS: 2US FAERS
105Medication ErrorFAERS: 2US FAERS
106Medication overuse headacheFAERS: 2US FAERS
107Mood swingsFAERS: 2US FAERS
108Muscle tightnessFAERS: 2US FAERS
109MyalgiaFAERS: 2US FAERS
110ParanoiaFAERS: 2US FAERS
111Personality ChangeFAERS: 2US FAERS
112Product quality issueFAERS: 2US FAERS
113Product residue presentFAERS: 2US FAERS
114Product solubility abnormalFAERS: 2US FAERS
115Product substitution issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Product taste abnormalFAERS: 2US FAERS
117Product use complaintFAERS: 2US FAERS
118RetchingFAERS: 2US FAERS
119Sexual DysfunctionFAERS: 2US FAERS
120SluggishnessFAERS: 2US FAERS
121SomnambulismFAERS: 2US FAERS
122TachycardiaFAERS: 2US FAERS
123ThirstFAERS: 2US FAERS
124AbasiaFAERS: 1US FAERS
125Adverse eventFAERS: 1US FAERS
126Allergy to chemicalsFAERS: 1US FAERS
127Anoxic EncephalopathyFAERS: 1US FAERS
128Apparent deathFAERS: 1US FAERS
129ArthropathyFAERS: 1US FAERS
130Arthropod biteFAERS: 1US FAERS
131Atrial FibrillationFAERS: 1US FAERS
132AutophobiaFAERS: 1US FAERS
133Bipolar DisorderFAERS: 1US FAERS
134BlindnessFAERS: 1US FAERS
135Blood glucose increasedFAERS: 1US FAERS
136BradycardiaFAERS: 1US FAERS
137BronchospasmFAERS: 1US FAERS
138CardiomegalyFAERS: 1US FAERS
139ChillsFAERS: 1US FAERS
140Choking sensationFAERS: 1US FAERS
141Clostridium difficile sepsisFAERS: 1US FAERS
142Cold sweatFAERS: 1US FAERS
143ColitisFAERS: 1US FAERS
144Conversion disorderFAERS: 1US FAERS
145CryingFAERS: 1US FAERS
146DeafnessFAERS: 1US FAERS
147DiverticulumFAERS: 1US FAERS
148DroolingFAERS: 1US FAERS
149Drug administration errorFAERS: 1US FAERS
150Drug dispensing errorFAERS: 1US FAERS
151Drug dose omissionFAERS: 1US FAERS
152Drug level fluctuatingFAERS: 1US FAERS
153Drug screen positiveFAERS: 1US FAERS
154DysgraphiaFAERS: 1US FAERS
155DysphoniaFAERS: 1US FAERS
156Ear discomfortFAERS: 1US FAERS
157Economic problemFAERS: 1US FAERS
158Emergency CareFAERS: 1US FAERS
159Emotional disorderFAERS: 1US FAERS
160Eye irritationFAERS: 1US FAERS
161Eye painFAERS: 1US FAERS
162FibromyalgiaFAERS: 1US FAERS
163Flight of ideasFAERS: 1US FAERS
164Gait inabilityFAERS: 1US FAERS
165Gastric BypassFAERS: 1US FAERS
166Gastrointestinal PainFAERS: 1US FAERS
167Gastrointestinal ulcerFAERS: 1US FAERS
168HypervigilanceFAERS: 1US FAERS
169Hypoaesthesia facialFAERS: 1US FAERS
170HypometabolismFAERS: 1US FAERS
171HypophagiaFAERS: 1US FAERS
172Illogical thinkingFAERS: 1US FAERS
173Inability to afford medicationFAERS: 1US FAERS
174IncoherentFAERS: 1US FAERS
175Increased bronchial secretionFAERS: 1US FAERS
176Insurance issueFAERS: 1US FAERS
177Intentional dose omissionFAERS: 1US FAERS
178Intentional product misuseFAERS: 1US FAERS
179Intercepted drug dispensing errorFAERS: 1US FAERS
180Intestinal ObstructionFAERS: 1US FAERS
181Intracranial AneurysmFAERS: 1US FAERS
182Joint injuryFAERS: 1US FAERS
183Joint swellingFAERS: 1US FAERS
184Ligament ruptureFAERS: 1US FAERS
185Lip swellingFAERS: 1US FAERS
186LymphadenopathyFAERS: 1US FAERS
187Maternal exposure during pregnancyFAERS: 1US FAERS
188Maternal exposure timing unspecifiedFAERS: 1US FAERS
189Mental impairmentFAERS: 1US FAERS
190Mental status changesFAERS: 1US FAERS
191Middle insomniaFAERS: 1US FAERS
192Motion SicknessFAERS: 1US FAERS
193Mouth swellingFAERS: 1US FAERS
194Muscle RigidityFAERS: 1US FAERS
195Musculoskeletal chest painFAERS: 1US FAERS
196Musculoskeletal stiffnessFAERS: 1US FAERS
197Nasal discomfortFAERS: 1US FAERS
198ObstructionFAERS: 1US FAERS
199PallorFAERS: 1US FAERS
200Panic DisorderFAERS: 1US FAERS
201PhotophobiaFAERS: 1US FAERS
202Platelet count abnormalFAERS: 1US FAERS
203Poor quality drug administeredFAERS: 1US FAERS
204Poor quality sleepFAERS: 1US FAERS
205Product difficult to swallowFAERS: 1US FAERS
206Reaction to drug excipientsFAERS: 1US FAERS
207Respiratory FailureFAERS: 1US FAERS
208Respiratory distressFAERS: 1US FAERS
209Rheumatoid ArthritisFAERS: 1US FAERS
210Rotator cuff syndromeFAERS: 1US FAERS
211ScreamingFAERS: 1US FAERS
212Skin irritationFAERS: 1US FAERS
213SplenomegalyFAERS: 1US FAERS
214StomatitisFAERS: 1US FAERS
215StressFAERS: 1US FAERS
216Sudden onset of sleepFAERS: 1US FAERS
217Suicide attemptFAERS: 1US FAERS
218Surgical failureFAERS: 1US FAERS
219SyncopeFAERS: 1US FAERS
220TachyphreniaFAERS: 1US FAERS
221Therapeutic response delayedFAERS: 1US FAERS
222Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
223Throat irritationFAERS: 1US FAERS
224ThrombocytopeniaFAERS: 1US FAERS
225Tongue blisteringFAERS: 1US FAERS
226Unresponsive to stimuliFAERS: 1US FAERS
227VasculitisFAERS: 1US FAERS
228Vulvovaginal drynessFAERS: 1US FAERS
229Wrong drug administeredFAERS: 1US FAERS
230YawningFAERS: 1US FAERS
231furuncleFAERS: 1US FAERS
232nervous system disorderFAERS: 1US FAERS
233WheezingCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.